Mylan N.V. ($MYL)$60M Investor Settlement
Mylan N.V. has reached a $60M settlement with $MYL investors to resolve claims that it engaged in a years-long scheme to fix prices for generic drugs and misled the public about its involvement in anticompetitive conduct.
Outline:
Investors claim Mylan colluded with competitors between 2013 and 2018 to inflate generic drug prices. They say the company publicly claimed compliance with antitrust laws while concealing the alleged scheme.
Reports and investigations later linked Mylan to the conduct, drawing subpoenas and increased scrutiny. As $MYL shares declined, investors sued over what they describe as misleading disclosures and omissions.
Timeline:
April 2016 – Mylan disclosed it had received a subpoena related to drug pricing practices
2017–2019 – Media reports and government investigations linked Mylan to an industry-wide price-fixing scheme
March 2018 – $MYL shares declined as further allegations surfaced
November 13, 2020 – Investors filed suit against Mylan N.V. for misleading disclosures and price-fixing involvement
December 2025 – Mylan agrees to a tentative settlement to resolve all claims
Background:
Investors allege Mylan colluded with other drugmakers between 2013 and 2018 to fix prices and divide market share for generic drugs, including essential medications. They say Mylan publicly denied wrongdoing and claimed compliance with antitrust laws despite the alleged conduct.
Regulatory scrutiny intensified in April 2016 when Mylan disclosed it had received a subpoena related to its drug pricing practices. Between 2017 and 2019, media investigations and government probes further tied Mylan to the broader alleged scheme.
As additional allegations surfaced in March 2018, investors point to a decline in $MYL shares. They claim the market reaction reflected growing concerns about Mylan’s legal exposure and the truthfulness of its public statements.
On November 13, 2020, investors filed a lawsuit alleging Mylan misled shareholders about its involvement and related risks. In 2025, Mylan agreed to a tentative settlement to resolve the claims.
What Can Investors Expect Now?
Mylan N.V. has reached a tentative settlement with $MYL investors to resolve claims that it engaged in a years-long scheme to fix prices for generic drugs and misled the public about its involvement in anticompetitive conduct.
If you were damaged due to this situation, you can file for a payout and get your share of the settlement. You can check if you are eligible and other details in the FAQ section below.
Frequently Asked Questions
All persons and entities who purchased or otherwise acquired Mylan N.V.’s publicly traded common stock between February 16, 2016 and May 7, 2019, inclusive.
No, if you have purchased securities within the class period, you are eligible to participate.
You can participate in the settlement and retain (or sell) your securities.
The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
The final payout amount depends on your specific trades and the number of investors participating in the settlement.
If 100% of investors file their claims - the average payout will be $0.11 per share. Although typically only 25% of investors file claims, in this case, the average recovery will be $0.44 per share.
If you're eligible, you can file your claim directly from this case page by clicking the "Collect Payout" button.
More than 100 companies are currently paying out settlements. Connect your brokerage account to automatically check which ones you may have missed — or file manually for this case.
11th.com is an investor recovery company that helps investors track and collect securities class action settlements. We will:
1. Prepare documents for your payout.
2. Audit the claim and make sure you get the maximum possible payout.
3. File a claim with the settlement administration.
4. Correspond with the settlement administration to resolve emerging issues.
5. Deliver payout directly to your brokerage account.
There is no upfront cost, but we will deduct 20% of the recovered amount as a commission for our services.